Join Dexcom as we present The Dexcom Portfolio: Empowering Healthcare Professionals and Their Patients Learn more about Dexcom’s G7 continuous glucose monitor (CGM) and Dexcom’s Stelo biosensor technology. The program will include information about considerations in care for people living with type 2 diabetes (T2D), the current Clinical Practice Guidelines, discussion about emerging clinical evidence supporting the use of CGM in T2D and the benefits of Dexcom CGM and biosensor for both providers and patients. Furthermore, you will be able to review Dexcom G7 and Stelo product information, including highlights of features.
Upon completion of the program, you should be able to: • Explain the benefits of using continuous glucose monitors and biosensors • Understand select guidelines related to RT-CGM • Identify patients who could potentially benefit from Dexcom G7 or Stelo
